Navigation Links
Morphine: a comfort measure for the dying or pain control for the living?
Date:12/10/2007

Cancer patients are suffering unnecessarily because they wrongly believe that morphine and other opioids are only used as comfort for the dying and as a last resort rather than seeing them as legitimate pain killers that can improve their quality of life.

In a study published online today (Tuesday 11 December) in the cancer journal, Annals of Oncology [1], experts in palliative care also say the belief that opioids hasten death is widely held amongst patients and this has a significant impact on pain management, as patients felt that an offer of opioids signified imminent death. Previous studies have estimated that between 40-70% of cancer patients may not have their pain properly controlled with the right medication for a variety of reasons.

Dr Colette Reid, the lead author of the study, said: If we are to employ the range of available opioids in order to successfully manage pain caused by cancer, we must ensure that morphine does not remain inextricably linked with death. If this connection stays in place then morphine will continue to be viewed as a comfort measure for the dying rather than a means of pain control for the living.

Dr Reid, a consultant in palliative medicine at the Gloucester Royal Hospital, Gloucester, UK, conducted in-depth interviews with 18 patients with metastatic cancer, aged between 55 and 82, who were asked to take part in a cancer pain management trial. She wanted to examine how patients reacted when first offered an opioid drug described as similar to morphine. Dr Reid also wanted to understand the factors that influenced patients decisions whether to accept or to reject morphine. The interviews were analysed along with an experienced social scientist Rachael Gooberman-Hill, and Geoffrey Hanks, professor of palliative medicine, both from the University of Bristol.

The patients interviewed were all white and half of them were women. Their views and experiences about morphine fell into four distinct
'/>"/>

Contact: Emma Mason
wordmason@mac.com
44-077-112-96986
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Proper Mattress Can Improve Sleep Comfort, Reduce Pain, Says American Chiropractic Association
2. New study examines brain-gut relationship in those suffering with stomach pain or discomfort
3. Test for lung cancer looks for discomforting quiet among protective genes
4. Experts Offer Tips on Easing Mammogram Discomfort
5. National Cherokee Inspired Comfort Award Winners Announced
6. March of Dimes NICU Family Support(R) Programs Give Wisconsin Families Comfort and Information during a Crisis
7. March of Dimes NICU Family Support(R) Programs Give Florida Families Comfort and Information During a Crisis
8. Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans
9. Use of certain lipid measures not more effective in predicting coronary heart disease
10. Wild American Shrimp Board Agrees To Implement New Self-Funding Measures
11. Valley Health System Caregivers, Members of SEIU UHW, to Announce Endorsement of Measure G
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... OSF Healthcare System has been ... Most Wired Survey conducted by Hospitals & Health Networks. This marks the fourth consecutive ... by The Sisters of the Third Order of St. Francis . , Health ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zaca Life ... the go. With no water needed, the refreshing berry-flavored tablets are the perfect ... get the natural ingredients that may help with body detoxification, protection and hydration,” ...
(Date:7/30/2015)... ... , ... The American Telemedicine Association (ATA) is seeking presentations ... on telemedicine, telehealth and mHealth. The meeting, expected to attract over 6,000 attendees ... 14-17, 2016 in Minneapolis, MN. , ATA’s annual meeting attracts the world’s most ...
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... health care throughout Orange, Riverside, Los Angeles, and San Bernardino counties, today announced ... the new Palliative Care Administrator. Dr. Demoratz is a strong proponent of early ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Beryl Institute announces its ... partnership with Patient Experience Institute, these offerings reinforce the commitment to help frame ... and throughout the experience movement, and provide information and research to support expanded ...
Breaking Medicine News(10 mins):Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 2Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 3Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3
... (Nasdaq: KNDL ) announced today that it ... the market closes on Wednesday, May 6, 2009. The ... webcast on Thursday, May 7 at 8:30 a.m. Eastern ... http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO ) Conference ...
... Pharmacy benefit manager Prime Therapeutics (Prime) announced today its ... Heart Walk. Prime is participating both as a sponsor ... 11 Blue Cross and Blue Shield Plans. Prime provides ... a deep commitment to improving the health of members," ...
... in 2017 for the Treatment of STEMI with ... from Decision ResourcesWALTHAM, Mass., April 23 Decision ... advisory firms for pharmaceutical and healthcare issues, finds ... mortality as the attribute that most influences their ...
... Expansion with Plans to Triple Overall Lab Capacity; Builds ... PLUS Diagnostics, a leading anatomic pathology company, announced today ... opening of a West Coast laboratory in Orange County, ... into a new laboratory in Union, New Jersey to ...
... InfoLogix, Inc. (Nasdaq: ... of enterprise mobility solutions for the healthcare and ... into an agreement with Gwinnett Medical Center ... suburban Atlanta, to deploy a next-generation, handheld Care ...
... ,high-glycemic, carbs, researchers say , , THURSDAY, April 23 (HealthDay News) ... workout may influence how many calories you burn during your ... rich in carbohydrates that do not cause a spike in ... burned 50 percent more fat during a post-breakfast workout than ...
Cached Medicine News:Health News:Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast 2Health News:For ST-Elevation Myocardial Infarction (STEMI), Interviewed Experts Indicate That The Medicines Company's Angiomax/Angiox Has Efficacy Advantages Over Sales-Leading ReoPro 2Health News:For ST-Elevation Myocardial Infarction (STEMI), Interviewed Experts Indicate That The Medicines Company's Angiomax/Angiox Has Efficacy Advantages Over Sales-Leading ReoPro 3Health News:PLUS Diagnostics Opens West Coast Laboratory to Support Increased Demand for Anatomic Pathology Services 2Health News:PLUS Diagnostics Opens West Coast Laboratory to Support Increased Demand for Anatomic Pathology Services 3Health News:InfoLogix Selected by Gwinnett Medical Center to Transform Clinical Care Through Next-Generation Mobile Communications Solution 2Health News:InfoLogix Selected by Gwinnett Medical Center to Transform Clinical Care Through Next-Generation Mobile Communications Solution 3Health News:A Pre-Workout Meal to Help You Burn Fat 2Health News:A Pre-Workout Meal to Help You Burn Fat 3
(Date:7/30/2015)... PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced ... second quarter ending June 30, 2015. ... We are excited to be near the completion of ... with topline results expected in the fourth quarter," stated ... Inc. "Translarna is now commercially available in 12 countries ...
(Date:7/30/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... regarding the notice it received on May 21, 2015 ... the Company was below certain of the Exchange,s continued ... 1101 of the NYSE MKT Company Guide, due to ...
(Date:7/30/2015)... 2015 Eisai Inc. announced today that regulatory ... States , European Union and Japan ... for eribulin, for the treatment of patients with inoperable ... for advanced or metastatic disease. These ... global Phase 3 clinical trial (Study 309), which met ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... Cepheid (NASDAQ: CPHD) ... Officer, received the Ernst & Young Entrepreneur Of The ... category. According to Ernst & Young LLP, the award ... in such areas as innovation, financial performance and personal ...
... 28, 2011 Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: ... Russell 3000®, Russell 2000® and Russell Global Indexes posted by ...   Annual reconstitution of Russell,s U.S. indexes captures ... May, ranking them by total market capitalization. Membership in the ...
Cached Medicine Technology:Cepheid CEO John Bishop Named Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award winner 2Cepheid CEO John Bishop Named Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award winner 3Cell Therapeutics Added to Russell 3000®, Russell 2000® and Russell Global Indexes 2Cell Therapeutics Added to Russell 3000®, Russell 2000® and Russell Global Indexes 3
Eye Bank Specular Microscope. Specular microscope for easy examination of corneal slice extracted from a donor....
... system uses prolene as thread-guide reducing time and ... Probe is inserted into the nasolacrimal duct and ... The probe is then withdrawn leaving the polypropylene ... diam silicone tubing into place. Newly coated with ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... conforms to natural anatomy of the ... on disposable inserter/dilator instrument for ease ... The Micro-Large plugs feature the unique ... shape of the eyelid. The slightly ...
Medicine Products: